This molecule could be behind liver fibrosis

The finding opens the door for a possible treatment for many liver diseases.

1:05 PM

Author | Kelly Malcom

liver lab notes
liver notes

The liver is the all-important organ behind processing of various substances we put into our bodies, from food and drink to alcohol and drugs. When things go awry with the liver, the consequences can be deadly. At the root of many liver diseases, from hepatitis to Non-Alcoholic SteatoHepatitis, commonly known as NASH, is scarring, otherwise known as liver fibrosis—and currently, there are no drugs available to treat this scarring.

Researchers are investigating the root causes of liver fibrosis in the hopes of identifying potential targets for drugs in the future. A U-M study identifies a molecule behind the runaway growth of bile duct cells inside the liver.

"Under disease conditions in the liver, there is injury to the bile duct cells," said Liangyou Rui, Ph.D., the Louis G. D'Alecy Collegiate Professor of Physiology. "The liver has to constantly regenerate new bile duct cells, which sometimes become malfunctional and causes inflammation and scarring."

This excessive bile duct production, Rui explains, has a special name: ductular reaction. Patients with ductular reaction have more disease complications and poorer outcomes.

In the paper, published in the journal Nature Communications, they describe a molecule called NIK that is highly activated in the malfunctioning bile duct cells. Using a genetically modified mouse model, they removed the NIK gene inside the bile duct cells.

"When removed, you prevent all of those bad things from happening," said Rui. Furthermore, treating normal mice with NIK inhibitors, molecules that can block the action of NIK, improved their liver disease.

How does NIK cause disease? Under normal circumstances, NIK promotes the regeneration of bile duct cells in response to the various toxic substances that the liver is exposed to while carrying out its normal duties. However, certain viruses, drugs, or other insults can hijack this normal restorative function and lead to excessive growth and the ductular reaction, as well as the secretion of inflammatory mediators that lead to scarring.

The team hopes to work with collaborators at U-M and elsewhere to develop new NIK-inhibitors to turn off this scarring process. The findings also have potential use as a therapy for a certain type of liver cancer called cholangiocarcinoma, which accounts for one third of all liver cancers and has very limited treatment options.

The paper's first authors are Zhiguo Zhang, Xiao Zhong, and Hong Shen of the U-M Medical School Department of Molecular & Integrative Physiology. Dr. Rui is the senior corresponding author. Additional authors are Liang Sheng, Suthat Liangpunsakul, Anna S. Lok, M Bishr Omary, and Shaomeng Wang.

Paper cited: "Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice," Nature Communications. DOI: 0.1038/s41467-022-32575-8.


More Articles About: Lab Notes All Research Topics Liver Conditions & Procedures
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories dad and daughter in hospital room in hospital beds and on right father and daughter standing together outside with blue michigan donor shits on
Health Lab
A daughter’s lifesaving gift to her father
The human liver can regenerate, making living donor liver transplants possible. Michigan Medicine’s Transplant Center is one of only a few in the country offering this option.
purple white
Health Lab
Study defines key driver of aggressive ovarian cancer
A study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.
pill being taken close up with water near hand
Health Lab
Patients are opting in for 10 years of breast cancer treatment
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.
mom with sick child on phone checking tempature
Health Lab
Drug that treats flu shows additional benefit of protecting close contacts from infection
One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about 30%, according to research.
cells spikey on pink background purple spikes
Health Lab
New clinical trials for pediatric brain tumors
Brain and spinal cord tumors account for one in four childhood cancers. Although 75% of children survive for at least five years after being diagnosed, many patients have recurrent tumors that cannot be cured. Andrea Franson discusses current therapies for pediatric brain tumors, how viruses can be used to target tumor cells and the new phase 1 trial that started in May 2025.
older women close up and blurred out by faces with an exit sign far away in red background and white writing
Health Lab
What makes someone leave a Medicare Advantage plan?
Medicare Advantage plans are the health insurance for half of all older adults; a study looks at what makes someone leave a plan or leave Medicare Advantage for traditional Medicare